Otherside Farms

JANUARY 23, 2019

Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. cancer cells (full – 2001). Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 Cannabinoid Receptor1 (full – 2001). full – 2001).

Cannabinoids 72

Cannabinoids Treatment Therapy Research and Development 72

Cannabis Law Report

MARCH 23, 2022

Psychedelic medicine could provide much needed treatment options for some mental health and neurological disorders in the near future. However, our drug laws impede research and deny patients access to these highly effective medicines. There are a number of differences between PAP and current treatment approaches.

Clinical Trials 52

Clinical Trials Treatment Medicine Access 52

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder.

Therapy 98

Therapy CBD Research and Development Treatment 98

Medicinal Genomics

JULY 18, 2023

Those with compromised immune systems, either through disease or medical treatment, are at serious risk of developing an aspergillosis infection. Due to the increased risk of contracting aspergillosis via organ transplant, some transplant programs have removed patients who use cannabis from their donor waiting list. Who is at risk?

Medicine 81

Medicine Patients Cannabis Therapy 81

The Cannigma

OCTOBER 14, 2021

Also, while the country did legalize the use of cannabis for medical reasons in 2012, it was only five years later that the country approved two licenses for patients to use a type of low THC cannabis flower supplied by Dutch cannabis provider Bedrocan. What Swedish law permits for medical patients. Can you grow your own weed?

Legalization 69

Legalization Policy THC Patients 69

Otherside Farms

JANUARY 23, 2019

1-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus (full – 1974). Anti-Tumor Effects (news – 2001?). Cannabis as a possible treatment for lung cancer (news – 2007). Cannabis as a possible treatment for lung cancer. A pilot study of orally administered ?1-trans-tetrahydrocannabinol

Oil 75

Oil Cannabinoids Medicine Treatment 75

Cannabis Law Report

AUGUST 27, 2022

The petitioners claimed that the treatment of cannabis at par with other harmful and lethal chemicals was arbitrary, unscientific and unreasonable. The PIL mentioned various studies pointing out the palliative effects of cannabis, particularly for terminally ill patients.

Consumption 98

Consumption Cultivation Research and Development Cannabis 98

CannaMD

OCTOBER 23, 2019

Medical conditions such as HIV/AIDS and cancer , and their related treatments, can also cause extreme nausea. As the study authors note: Enhancing endocannabinoid system signaling may represent an alternative therapeutic strategy for motion sickness in individuals who do not respond to currently available treatments.

Research and Development 61

Research and Development Marijuana Treatment Cannabinoids 61

Cannabis Law Report

MARCH 1, 2019

Cannabis, for medicinal purposes, was legalised nearly four months ago in the UK, but how many patients are actually reaping the benefits, and how far have we really come? When medicinal cannabis was legalised in the UK in November 2018, many people, especially medical professionals and patients, welcomed the decision with open arms.

Medicine 45

Medicine Clinical Trials Patients Treatment 45

Medicinal Genomics

AUGUST 8, 2023

Those with compromised immune systems, either through disease or medical treatment, are at serious risk of developing an aspergillosis infection. Due to the increased risk of contracting aspergillosis via organ transplant, some transplant programs have removed patients who use cannabis from their donor waiting list. Who is at risk?

Medicine 52

Medicine Patients Cannabis Therapy 52

Medicinal Genomics

JULY 18, 2023

Those with compromised immune systems, either through disease or medical treatment, are at serious risk of developing an aspergillosis infection. Due to the increased risk of contracting aspergillosis via organ transplant, some transplant programs have removed patients who use cannabis from their donor waiting list. Who is at risk?

Medicine 52

Medicine Patients Cannabis Therapy 52

Cannabis Law Report

JULY 12, 2019

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

AUGUST 15, 2019

Using cannabis-based products and narcotics in general for medical treatment is permissible in the following cases: If the need for using such substance was an absolute necessity or “dharura” because necessity is the only exception that can make what originally forbidden to permissible. Cannabis-Sharia-Finance. [1]

Law 65

Law Banking Conditions Topical 65

CannaMD

SEPTEMBER 10, 2020

As medical marijuana becomes more readily available, it has become an increasingly popular option for the treatment of nausea and morning sickness during pregnancy. A physician may not issue a physician certification, except for low-THC cannabis, to a patient who is pregnant. Find Out if You Qualify. Get Started. Join 55K+ Subscribers!

Marijuana 60

Marijuana Therapy Data THC 60

Greencamp

MAY 1, 2019

Marijuana for nausea became FDA approved and available for medicinal use in 1985 in the US, and Canada legalized it for these purposes back in 2001. Since then, countless patients found relief in cannabis, even though most of the times doctors would only recommend it when all other “mainstream” options were exhausted. References.

Patients 89

Patients Strains Sativa Marijuana 89

Veriheal

MAY 18, 2023

annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. Nonetheless, guidelines pertaining to the use of cannabis-based treatments for chronic pain relief have been somewhat hazy…up until now. Chronic pain —a condition that affects 50.2

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

The Cannigma

MAY 19, 2021

Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. CBD has become especially trendy in Tokyo, where CBD shops and cafes allow for the on-site consumption of CBD in edibles and topical treatments. Shutterstock). Who can get medical cannabis in Japan?

Law 137

Law Legalization Clinical Trials CBD 137

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Dr. Michele Ross

DECEMBER 11, 2018

Approximately 10 million patients in the United States have fibromyalgia, and 75-90% are women. Patients with lupus, osteoarthritis, and or rheumatoid arthritis are at higher risk of developing fibromyalgia. What Are The Common Treatments For Fibromyalgia? In a pilot study of nine patients, THC in doses of 2.5-15

Research and Development 66

Research and Development Therapy Patients Treatment 66

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 110

Consumption Patients Research and Development Data 110

Veriheal

JULY 22, 2021

According to New Jersey, bill A1708 would require that “personal injury protection automobile insurance benefits and workers’ compensation benefits must include coverage for costs associated with the medical use of marijuana provided that the insured or the employee is a qualifying patient.”

Patients 98

Patients Medicine Treatment State Laws 98

The Cannigma

JANUARY 13, 2023

The fact that migraine is now ranked as the second leading cause of years lived with disability illustrates the magnitude of the negative impact of the disease to patients and their ability to function normally. A 2019 retrospective review of 316 patients found that medical cannabis improved the experience of 88.3% headaches per month.

Terpenes 132

Terpenes Strains THC Treatment 132

SpeedWeed

MARCH 6, 2021

Chemotherapy patients experiencing neuropathic pain may find relief from cannabis, according to a new study published last month. Oxaliplatin, the researchers said, “is a platinum-based chemotherapy widely used for the treatment of gastrointestinal (GI) malignancies.” A large prospective trial is planned.”.

Treatment 52

Treatment Patients Data Cannabis 52

WeedAdvisor

MAY 19, 2019

legalized medical marijuana on November 1 st of last year – roughly 18 years after one of its closest Commonwealth allies, Canada, set up its own medical cannabis program in 2001. Only consultants can prescribe these specials and many of them don’t think cannabis is as effective as existing treatments.”. NHS Still Hesitant.

Access 49

Access Legalization Treatment Advocacy 49

CannaTech

SEPTEMBER 16, 2018

Canada has been at the forefront of shaping much of the rhetoric surrounding cannabis since 2001. Doctors have remained integral parts of a patient’s cannabis journey through what is known as the Access to Cannabis for Medical Purposes Regulation (ACMPR) act. The Need for Cannabis Education Tailored to Patient and Doctor.

Education 66

Education Medicine Clinical Trials Patients 66

Cannabis Law Report

OCTOBER 20, 2019

It is also the first FDA approved drug for the treatment of patients with Dravet syndrome. Big Pharma companies want botanical marijuana to remain illegal because it is financially beneficial to them, not because synthetic marijuana is decidedly better for patients.” Four of them are now on the market. marijuana companies.

Marijuana 45

Marijuana Pharmaceutical Chronic Pain Research and Development 45

Puff Puff Post

SEPTEMBER 24, 2019

Cannabis was a popular medical aid for patients suffering from rheumatic diseases and to help alleviate nausea. . It was not until the 1990’s that the government felt the pressure of thousands of medical patients advocating and fighting for the use of cannabis. Tax exemption: .

History 94

History Cannabinoids Indica Tincture 94

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. On May 3, 2021, our study of MDMA-assisted therapy for PTSD achieved successful results for patients with severe, chronic PTSD.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

AUGUST 19, 2019

The main relevant UK legislation is the Misuse of Drugs Act 1971 (the Act) and the Misuse of Drugs Regulations 2001 (as amended by the Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales and Scotland) Regulations 2018) (the Regulations). What is the relevant legislation?

Environment 45

Environment Food Seed-To-Sale Medicine 45

Cannabis Law Report

FEBRUARY 23, 2019

Mr O’Brien also runs the longest running dispensary in the world: The Patients Care Collective in Berkely. He opened the doors on April 4, 2001, and, remarkably, was never raided. What made the Patients Care Collective different? “We We were patient-focused,” he said. Our little dispensary was never targeted.

Cultivation 40

Cultivation Patients Compliance Compliance 40

WeedAdvisor

MARCH 16, 2019

According to Marijuana Business Daily : “The volume of medical cannabis oil sold in Canada’s regulated market rose to nearly 5,000 kilograms (11,023 pounds) in January compared with the 4,400 kilograms shipped to patients in October 2018”. Although many patients were shorted for a brief period, the problem was soon resolved.

Legalization 40

Legalization Marijuana Recreational Oil 40

SpeedWeed

FEBRUARY 19, 2021

They retted the stems and twisted the fibers into sturdy ropes and ground the plant to make a soothing eyewash, a treatment they recorded in the medical papyri. Pringle, 2001). Both eyes of the patient are to be washed with it in the morning.”. Pringle, 2001). But the Egyptians made little mention of the other parts of C.

Research and Development 52

Research and Development Cannabis Hemp Concentrates 52

Cannabis Law Report

SEPTEMBER 14, 2021

Patent 6630507, which identifies the medicinal benefits of cannabinoids, the compounds found in cannabis; and WHEREAS, in 2013, the American Civil Liberties Union (ACLU) published an unprecedented national report on cannabis possession arrests, “The War on Marijuana in Black and White” which analyzed data from all 50 states and the District (..)

Policy 98

Policy Research and Development Access Cannabis 98

Cannabis Law Report

SEPTEMBER 14, 2019

Currently the growth of this industry domestically is inhibited by the existing regulatory framework that limits patient access to medicinal cannabis and the high cost for treatment due to medicinal cannabis products not being subsidised under the Pharmaceutical Benefits Scheme.

Law 45

Law Medicine Cultivation Hemp 45

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Patients should first meet with a health-care practitioner to determine if cannabis can be beneficial in treating their symptoms. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

JUNE 4, 2021

there has never been a better time for new treatment options. Sessa is also the Chief Medical Officer of Awakn Life Sciences, and has been a part of scientific and clinical studies administering LSD, psilocybin, ketamine, MDMA and DMT to patients and volunteers. Brian Muraresku. in/julie-holland-b1a7a13/ [link]. Bia Labate. Bia Labate.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

SEPTEMBER 19, 2019

Medicinal cannabis was technically legalised at the start of November 2018 following several high-profile cases about children with severe forms of epilepsy being unable to access potentially life-changing cannabis-based treatment. The firm was founded in 1998 and listed on AIM in 2001 before it left London to join the NASDAQ in 2013.?Over

Pharmaceutical 40

Pharmaceutical Research and Development Medicine Oil 40